ACB
OGI Smashes Expectations But Actual Results are a House of Cannabis Horrors.
Organigram (NASDAQ: OGI) beat lowered analyst estimates but dig a little deeper and the big stock price spike looks like…
Aphria (APHA) Earnings – Guidance Cut But Still the Best Game in Town
Aphria (TSE: APHA; NYSE: APHA) earnings showed it has the cash to weather the coming storm and the profitability to…
GW Pharmaceuticals Releases a Q4 Revenue Beat, but Will the Rapid Growth Continue?
Bottom Line Cannabinoid prescription medicine company GW Pharmaceuticals (NASDAQ: GWPH) pre-announced revenues for its fourth quarter and full-year last night.…
Is Aurora Cannabis Headed for a Technical Bankruptcy?
With a huge writedown likely in the next two months, can Aurora Cannabis (ACB) avoid a technical bankruptcy and a…
Aurora Signals Mayday as Chief Promotional Officer Cam Battley Resigns
Aurora Cannabis (TSE: ACB) announced the resignation of Chief Corporate Officer Cam Battley, with no rationale given, investors are left…
HEXO About to Learn What it Means to Sink or Swim After Scary Earnings Report
Bottom Line After digging through the earnings of HEXO it's clear this company is not in a good place. Here…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (December 14th, 2019)
Drowning in Ditch Weed, Canada's Oversupply Endgame Bottom Line: The problems the cannabis market now faces were foreshadowed in-depth…
Aurora Cannabis Backed Australis Converting to a Hemp Producer
Australis-Folium Merger Forms Potent CBD Company Aurora Cannabis owned investment vehicle Australis Capital (CSE: AUSA; OTC: AUSAF) announced today that…
Drowning in Ditch Weed, Canada’s Oversupply Endgame
Will the rollout of new cannabis products save the industry from a mounting oversupply in 2020? We dive deep to…